Han Kun represented Rodman & Renshaw in China Cord Blood Corporation's listing on NYSE
2009-11-23
China Cord Blood Corporation ("CCBC") Listed its Ordinary Shares on NYSE.
On November 19, 20009, CCBC completed its secondary public offering and successfully listed its ordinary shares on NYSE's main board under the ticker symbol "CO". The secondary public offering of approximately 3.3 million ordinary shares at US$6.05 per share generated gross proceeds of US$20 million. CCBC is the first and the largest cord blood banking operator in China in terms of geographical coverage and is the only cord blood banking operator with more than one license (i.e., Beijing and Guangdong).
Han Kun primarily assisted Rodman & Renshaw, the bookrunner for this secondary offering, in reviewing the F-1 statement filed with the SEC and giving comments and suggestions on issues involving PRC laws and regulations.